A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing albuterol ... system for asthma and chronic obstructive pulmonary disease (COPD ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment ... to patients with asthma and COPD under a 510(k) over ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.

One red inhaler contains the rescue medication albuterol. Another red inhaler is a combination ... 2016.81 American Lung Association. Asthma and COPD Medicines. National Heart, Lung, and Blood ...

Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Scientists at Rutgers Health have discovered that a simple blood test could diagnose asthma and determine its severity, a ...

Because of the challenge of oral and subcutaneous treatments in the terminally ill, nebulized forms of treatment have been examined. [12] Inhalation therapy can typically be done at home ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

In asthma, lower end-tidal carbon dioxide may predict acute exacerbation outcomes, although other measures may be better severity indicators.